Table 2.
Participants’ characteristics
| Total Sample | Localized OA+T2D | Localized OA Only | P Value | |
|---|---|---|---|---|
| N = 819 | N = 148 | N = 671 | ||
| Age, mean ± SD, y | 64.1 ± 10.2 | 66.38 ± 9.42 | 63.58 ± 10.32 | 0.002 |
| Gender, female, No. (%) | 374 (54.3) | 81 (54.7) | 364 (54.2) | 0.49 |
| Body mass index, mean± SE, kg/m2 | 31.71 ± 0.35 | 33.90 ± 0.70 | 31.21 ± 0.41 | 0.003 |
| Hypertension, No. (%) | 401 (49.0) | 115 (77.7) | 286 (42.6) | < 0.001 |
| Dyslipidemia, No. (%) | 251 (30.6) | 82 (55.4) | 169 (25.2) | <0.001 |
| Depression, No. (%) | 84 (10.3) | 28 (18.9) | 56 (8.3) | <0.001 |
| Medications, No. (%) | ||||
| Insulin | 91 (11.1) | 91 (61.5) | 0 (0.00) | <0.001 |
| Hypoglycemic | 99 (12.1) | 77 (52.0) | 22 (3.3) | <0.001 |
| Antihypertensive | 186 (22.7) | 57 (38.5) | 129 (19.2) | <0.001 |
| Antilipemic | 366 (44.7) | 92 (62.2) | 274 (40.8) | <0.001 |
| Antidepressants | 230 (28.1) | 49 (33.1) | 181 (27.0) | 0.08 |
| Opioid | 759 (92.7) | 127 (85.8) | 632 (94.2) | 0.001 |
| Nonopioid | 624 (76.2) | 114 (77.0) | 510 (76.0) | 0.44 |
| Benzo | 670 (81.8) | 114 (77.0) | 556 (82.9) | 0.06 |
| HbA1c, n = 87 mean ± SD | - | 7.03 ± 2.01 | - | - |
| Pain intensity, mean ± SD | 5.36 ± 2.84 | 6.22 ± 2.85 | 5.17 ± 2.80 | <0.001 |
OA = osteoarthritis; T2D = type 2 diabetes.